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Abstract
Background: The Neuronal Ceroid Lipofuscinoses (NCL) comprise at least nine progressive neurodegenerative genetic
disorders. Kufs disease, an adult-onset form of NCL may be recessively or dominantly inherited. Our study aimed to identify
genetic mutations associated with autosomal dominant Kufs disease (ADKD).
Methodology and Principal Findings: We have studied the family first reported with this phenotype in the 1970s, the Parry
family. The proband had progressive psychiatric manifestations, seizures and cognitive decline starting in her mid 20 s.
Similarly affected relatives were observed in seven generations. Several of the affected individuals had post-mortem
neuropathological brain study confirmatory for NCL disease. We conducted whole exome sequencing of three affected
family members and identified a pLeu116del mutation in the gene DNAJC5, which segregated with the disease phenotype.
An additional eight unrelated affected individuals with documented autosomal dominant or sporadic inheritance were
studied. All had diagnostic confirmation with neuropathological studies of brain tissue. Among them we identified an
additional individual with a p.Leu115Arg mutation in DNAJC5. In addition, a pAsn477Ser change in the neighboring gene
PRPF6, a gene previously found to be associated with retinitis pigmentosa, segregated with the ADKD phenotype.
Interestingly, two individuals of the Parry family did report visual impairment.
Conclusions: Our study confirmed the recently reported association of DNAJC5 mutations with ADKD in two out of nine
well-defined families. Sequence changes in PRPF6 have not been identified in other unrelated cases. The association of
vision impairment with the expected PRPF6 dysfunction remains possible but would need further clinical studies in order to
confirm the co-segregation of the visual impairment with this sequence change.
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Introduction
Neuronal Ceroid Lipofuscinoses (NCL), also referred to as
Batten Disease, are a group of at least 9 genetic disorders,
characterized by progressive neurodegeneration and early death.
A unifying feature of these devastating conditions is the lysosomal
accumulation of autofluorescent lipopigment in neuronal cells
[1,2]. Electron microscopy (EM) studies of peripheral cells
demonstrate specific storage inclusions in the lysosomes in some
of these patients. Adult-onset NCL, also referred to as Kufs disease
is classified into two categories with autosomal recessive (MIM
204300) or dominant (MIM162350) inheritance. In the majority of
families with recessively inherited Kufs disease, mutations in the
gene CLN6 that are usually associated with early-onset NCL were
recently reported [3]. No genetic defect associated with Autoso-
mal-Dominant Kufs disease (ADKD) was known until very
recently. An article describing mutation in the gene DNAJC5 in
patients with ADKD by Noskova et al. [4] was published while the
current study was at its final stage. Noskova and colleagues
reported two mutations in DNAJC5 in five unrelated families or
single individuals out of total of 20 studied individuals/families.
Seven of the mutation-negative individuals/families studied by this
group did not have documented family history so it was not clear if
recessive inheritance was ruled out for these families. In addition,
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29729five of the families were reported with recessive inheritance. Most
importantly, for the families negative for the DNAJC5 mutations
no evidence of neuropathological confirmation of the diagnosis
was presented. Kufs disease is a disorder presenting with rather
non-specific features of progressive neurodegeneration including
seizures, psychiatric manifestations and progressive dementia. It is
often difficult to be certain in this diagnosis without observing,
usually postmortem, characteristic changes in neuronal cells. Here
we report our own approach that led to the identification of
DNAJC5 mutations in two families, thereby confirming the recent
study by Noskova et al [4]. We also present detailed clinical up-to-
date on the proband of the Parry family. Finally, we estimate the
proportional contribution of DNAJC5 changes to all families with
ADKD.
Methods
Objectives
To identify genetic mutations segregating with the phenotype in
the originally reported family with ADKD.
To study additional, unrelated individuals, and estimate the
mutations prevalence in affected individuals.
Subjects
A. The Parry family. The family studied here was first
reported in the 1970s [5]. Since it is the first family reported with
this disorder, the ADKD is often referred to as the Parry type or
Parry disease.
Proband: The proband (individual VI-2 from the Parry pedigree
in Figure 1) is a 49 year-old woman, who was in good health until
her mid 20 s. At the age of 26 years she had several evaluations by
different clinicians because of increasing irritability and obsessive-
compulsive manifestations. She was worried that her house was not
clean, was seen frequently washing her hands before touching her
three children and quit her job because she believed that she might
contract HIV from objects at work. Her EEG at that time was
moderately abnormal with generalized recurrent brief bursts of
moderate to high voltage 4–6 Hz slow waves, often with a semi-
rhythmic pattern, and admixed sharp forms. On psychiatric
assessment she appeared anxious and depressed, but she had intact
memory. Otherwise her examination was normal. At the age of 32
years she had her first generalized seizure. She had normal brain
CT scan at the age of 33 years and normal brain MRI at the age of
34 years. After her first seizure episode she gradually developed
memory loss and an ataxic gait. At the age of 49 years, about every
month around the time of her period, she had 1–2 day periods of
multiple seizure events. She was able to ambulate with a cane. Her
short-term memory was affected, but her long-term memory was
relatively spared. Starting in her 40 s she complained of seeing
‘‘yellow blinding lights’’. This complaint has progressively increased
in frequency. Ophthalmologic examinations have been normal up
until the final reported examination at the age of 34 years.
Other family relatives from the Parry family: All affected
individuals from the family had a history of progressive seizure
disorder, ataxic gait, and progressive dementia, with the first
manifestations typically starting in their 20 s or 30 s. We have
compiled information on 7 generations of the individuals of this family
and matched the individuals’ numbers with the ones reported in
reference 5. Of interest is that one of the originally reported affected
relatives (individual IV-2) had complaints similar to the proband of a
‘‘visual aura of bright spots’’ beginning at the age of 39 years.
The proband’s mother died at the age of 40 years with clinical
diagnosis of Kufs disease and a brain autopsy revealed neuronal
autofluorescent inclusions thus supported the clinical diagnosis.
Detailed information was previously reported in three individuals
of this family: IV-2, IV-3 and IV-7 [5]. Brain autopsy results were
previously reported in individuals IV-2 and IV-3, and both were
confirmatory for NCL disease. The proband’s clinically unaffected
brother (individual VI-3) had a normal EEG examination and
normal neurological examination at the age of 22 years.
Seven individuals from this family in addition to the proband
were included in our study. All unaffected individuals studied were
older than 32 years in order to avoid including preclinical
individuals in our analysis.
B. Other individuals studied. Eight additional individuals/
families were included in the study. Four of them were with
documented familial, autosomal-dominant inheritance and four
were sporadic. All of them presented with a progressive
neurodegenerative disorder with manifestations starting between
the ages 16 and 35 years, and consisting of seizures, progressive
dementia, unstable gait and behavioral changes, sometimes
including frank psychiatric manifestations. No vision deficits
were reported in these individuals. Confirmation of the diagnosis
of Kufs disease was made in all individuals with neuropathological
study of brain tissue in the proband or in affected family relative.
Summary of the clinical manifestations of the studied individuals is
shown on Table 1. Results of neuropathology and EM studies of
peripheral cells in some of the individuals are shown on Figure 2.
The results of laboratory studies are summarized on Table 2.
Patient KUF04SR was previously reported [6]. This patient was
also included in the study of Noskova et al [4].
The gene CLN6 that was previously reported in association with
autosomal-recessive Kufs disease was sequenced in all the sporadic
individuals studied and no mutations in this gene were identified.
Description of Procedures or Investigations taken
A. EM studies of peripheral cells. We have conducted EM
studies of peripheral cells of the proband of the Parry family at
three different ages, and of individual V-28 of the same family in
order to monitor for NCL-specific lysosomal inclusions as
previously described [2].
B. Exome sequencing. Enrichment of coding exons and
flanking intronic regions was performed on three individuals of the
pedigree in Figure 1: VI-2, V-1 and V-28. We applied the
SureSelect Human All Exon 50 Mb kit (Agilent) following the
manufacturer’s standard protocol. The kit encompasses coding
exons annotated by the GENCODE project, CCDS, and RefSeq
databases and also incorporates a number of non-coding RNAs.
The protocol allowed for integration of Illumina’s Hiseq2000
adapter sequences and indexed multiplexing of multiple samples
per flow cell lane. Enriched DNA was subjected to standard
sample preparation for the Hiseq2000 instrument (Illumina).
C. Sanger Sequencing. Sanger sequencing was performed to
confirm existence and segregation of identified variants and to
screen for additional mutations in the two candidate genes PRPF6
and DNAJC5. For these genes all exons and flanking intronic
sequences were amplified on Applied Biosystems (ABI) Veriti 96-
well Fast Thermal Cyclers using a touchdown protocol. Polymerase
chain reaction (PCR) purification was completed with
QuickStepTM2 SOPE resin (Edge BioSystems). Sequencing was
performed using ABI BigDye Dye Terminator Cycle Sequencing
Kit on an ABI 3730 sequencer. Sequence traces were analyzed
using Sequencher (version 4.8; Gene Codes Corporation).
D. Bioinformatics Analysis. Raw sequencing data were
analyzed using version 1.7 of the Illumina analysis pipeline.
Sequence reads were aligned with the MAQ software. MAQ is a
widely used short read mapping software for next-generation
sequencing data. MAQ first aligns reads to reference sequences
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PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e29729Figure 1. Updated pedigree of the Parry family. Individuals included in this study are indicated with star symbols on top of individual’s number.
The proband is marked with an arrow. One of the individuals in generation V was marked V-1A in order to match the individual numbers with the
ones in the initially published Parry pedigree, reference 5.
doi:10.1371/journal.pone.0029729.g001
Table 1. Clinical manifestations in probands from the families or sporadic affected individuals included in the study.
Proband ID Clinical summary Family history
P-VI-2 (Parry) See text See Figure 1and reference 5
BD 319 The early growth and development were normal. Seizures and gradual dementia
started in mid 30 s. Interictal EEG was abnormal. No vision problems were reported.
Neuropsychological testing revealed borderline cognitive functioning. Tendencies for
denial and presenting himself in an overly favorable light were noted on
psychological evaluation. Difficulties speaking, ataxia and involuntary movements
developed in early 40 s. At 46 he had difficulties swallowing. Patient died at the
age of 54 years.
No affected family relatives were reported
BD 303 At the age of 32 started having headaches, memory problems, difficulties speaking
and coordination problems. No vision impairment was reported. Interictal EEG was
abnormal, but no clinical seizure activity was observed. Brain MRI showed diffuse
brain atrophy. Patient died at the age of 36.
This patient’s father, paternal grandmother and
brother were affected with similar progressive
neurodegenerative disorder and died in their
30 s.or early 40 s
BD 160 In her mid 20 s this individual started having difficulties speaking, ataxia and
seizures. The patient died at the age of 38.
The patient’s brother and father had similar
manifestations
KUF01CH At 38 years of age this patient developed myoclonus and anxiety disorder.
The interictal EEG was normal.
The patient’s father developed involuntary
movements, ataxia and memory loss in his 70 s
KUF04SR Absence seizures started at the age of 5, episodic tremors started in the 20 s,
generalized seizures since 28 and intellectual decline documented at 31. See also
reference 6.
Autosomal-dominat (see reference 6)
BD-AW This individual died at the age of 26 from progressive neurodegenerative disorder
starting in her 20 s.
No other affected relatives were reported
BD-SS Learning, speaking and walking difficulties and involuntary movements started
at the age of 15. No vision impairment was reported. Seizures started at 23. Brain
MRI showed cerebral atrophy.
No other affected relatives were reported
BD-185 Seizures and memory loss started at 16. No other affected relatives were reported
doi:10.1371/journal.pone.0029729.t001
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which maximizes the posterior probability and calculates a quality
score at each position along the consensus (http://maq.
sourceforge.net/index.shtml).
Variants were called with MAQ applying the standard
parameters. All variants were submitted to SeattleSeq for further
categorization into coding, noncoding, and novel single-nucleotide
polymorphisms (SNPs). SeattleSeq is a genomic annotation server
that provides batch annotation of SNPs (single-nucleotide
polymorphisms), both known and novel (http://snp.gs.washing
ton.edu/SeattleSeqAnnotation). Resulting data were converged,
filtered, and ranked by Genomic Evolutionary Rate Profiling
(GERP) conservation scores.
E. Genotyping and haplotype analysis. Genotyping of the
DNAJC5 locus was performed with Sanger sequencing. The
genotypes were phased based on the segregation pattern within the
pedigree and haplotypes were constructed from consecutive single
nucleotide variants. Disease co-segregating haplotypes were
compared to the published alleles in Noskova et al.
Ethics
This study was conducted according to protocols approved by
the Institutional Review boards of the New York State Institute for
Basic Research in Developmental Disabilities and the Institutional
Review Board of Massachusetts General Hospital. The study was
conducted according to principles of the Declaration of Helsinki.
All subject studied signed an informed consent for study
participation.
Results
Electron microscopy studies
Lysosomal inclusions in peripheral cells are typically observed in
certain types of NCL patients. The proband of the Parry family
had three EM studies on peripheral lymphocytes and one study of
fibroblast cells. The studies of peripheral lymphocytes were done
at 26, 34 and 36 years of age. Two of the studies were negative for
Table 2. Laboratory, neuropathology studies and DNAJC5 mutation status of probands from the families included in the study.
Proband ID Peripheral cell studies Neuropathology studies DNAJC5 gene changePRPF6 gene change
P-VI-2 (Parry) See text See text and reference 5 pLeu116del pAsn477Ser
BD-319 Not available Brain biopsy at the age of 38: microscopy showed
neuronal storage material that stained intensely with
PAS stain and was autofluorescent under fluorescent light.
EM* of brain tissue revealed GROD** in the neuronal
cytoplasm
pLeu115Arg negative
BD-303 EM in fibroblasts showed
curvilinear bodies and
lipofuscin granules
Post mortem brain neuropathology reportedly
confirmed the diagnosis of Kufs disease
negative negative
BD-160 EM demonstrated GROD
inclusions in fibroblasts.
Brain autopsy showed GROD inclusions in
neuronal cells.
negative negative
KUF01CH Rectilinear and GROD in
peripheral lymphocytes
(Figure 2)
Postmortem neuropathology study of the patient’s
father showed PAS positive inclusions and granular
osmiophilic inclusions in neuronal cells in electron
microscopy
negative negative
KUF04SR Not available Brain neuropathology: microscopy: PAS positive,
autofluorescent neuronal inclusions; electron
microscopy: osmiophilic inclusions with rectilinear
or curvilinear morphology
negative negative
BD-AW Not available Postmortem electron microscopy study of brain
tissue showed fingerprint and curvilinear inclusions
negative negative
BD-SS Normal study of peripheral
lymphocytes and fibroblasts
at the age of 24.
Brain biopsy: microscopy: PAS positive and
autofluorescent storage material. EM: positive for
osmiophilic neuronal inclusions.
negative negative
BD-185 Not available Brain neuropathology (brain biopsy) PAS positive and
autofluorescent neuronal inclusions. EM showed
osmiophillic inclusions
negative negative
*EM=Electron microscopy;
**GROD=Granular osmophilic deposits.
doi:10.1371/journal.pone.0029729.t002
Figure 2. Laboratory studies of some of the individuals
studied. a) EM study of peripheral lymphocytes of the proband of
the Parry family showing storage inclusions with morphology of GROD
(arrows). Higher magnification of the area is shown in the upper right
corner. b) Neuropathology study of the father of individual KUF01CH
showing neuronal accumulation, throughout the CNS, of PAS-positive
material with strong, broad-range autofluorescence.
doi:10.1371/journal.pone.0029729.g002
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the age of 34 years revealed granular osmiphilic deposits (GROD)
and curvilinear lysosomal inclusions in only two out of 112 cells
studied. The clinically affected individual V-28 from the same
family was also studied with electron microscopy at the age of 38
years. Her peripheral lymphocytes were negative for lysosomal
inclusions.
Exome sequencing and genetic studies
We performed exome sequencing on three affected family
members of the Parry family. After alignment and variant calling
30,148 coding single nucleotide variants were identified across all
individuals. Filtering for segregation of non-synonymous and
heterozygous variants reduced this number to 14,683 and 911
changes respectively. Only 111 changes were not reported in
dbSNP v132 and 8 changes had a GERP conservation score above
zero. These changes represented top candidates for this very rare
disease. Sanger sequencing found only one variant completely
segregating in the pedigree. This change c.A1430G, represented a
missense variant in the gene PRPF6, Asn477Ser. The variant was
highly conserved (GERP score 5.11; PhastCons: 0.957) and the
change was not present in 2,100 control individuals.
Indel analysis revealed 5,464 variants segregating between the
three exomes. Of these 109 changes were coding or affected a
splice site and only four indels were not in dbSNP v132. As
confirmed by Sanger sequencing, a deletion in the gene DNAJC5,
c.346_348delCTC, p.Leu116del, was the only indel completely
co-segregating with the phenotype in the pedigree (Fig. 1).
Both changes in the genes PRPF6 and DNAJC5 occurred within
,75 kb on chromosome 20 (Fig. 3). We conclude that they are
physically linked on a rare haplotype. To further decide which
gene represented the cause for ADKD we Sanger-sequenced all
coding exons of the two genes in eight additional families (Table 1).
We identified a Leu115Arg change in DNAJC5 in one additional
unrelated ADKD sample (see Table 1). This latter change
occurred very close to the in-frame deletion Leu116del, in a
highly conserved residue and is predicted to be pathological. This
missense mutation was not present in 2,100 control subjects. No
changes in PRPF6 were identified in individuals unrelated to the
Parry family.
Haplotype reconstruction with genetic markers in DNAJC5
showed that the studied affected individuals from the Parry family
do not share haplotype with any of the families reported by
Noskova et al [4] supporting the existence of a mutation hotspot
rather than founder effect for the DNAJC5 deletion (Table 3).
Haplotype analysis of individual BD319 also did not show overlap
with haplotypes of individuals with the Leu115Arg changes
reported by Noskova et al (Table 4).
Figure 3. Identification of DNA variants in DNAJC5 and PRPF6. a) Schematic of the region on chromosome 20 containing DNAJC5 and PRPF6 in
close proximity. b) Sanger sequence traces of the identified segregating variants in DNAJC5 and PRPF6. c) The two very rare changes identified in the
Parry family Leu116del (in DNAJC5) and N477S (in PRPF6) were highly conserved in different species. A second change in DNAJC5, Leu115Arg, was
also highly conserved.
doi:10.1371/journal.pone.0029729.g003
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Leu116del
Parry VI:2 Parry V:27 Parry V:28 Parry associated haplotype UCL519 P1
rs2065993 A/A A/G A/G A G/A G/G
rs2247381 G/G A/G A/G G A/G A/A
rs2427546 C/C T/C T/C C T/C T/T
rs2427547 G/G A/G G/G G A/G A/A
rs2427550 A/A C/A C/A A C/A C/C
rs2427551 G/G A/G A/G G A/G A/A
rs2427552 G/A G/G G/G G G/G G/G
rs6011225 C/C A/C C/C C C/C A/A
rs2427549 C/C C/T C/T C C/C C/C
rs2427548 T/T C/T C/T T C/C C/C
rs2427553 A/A C/A C/A A C/A C/C
rs6062586 T/T C/T C/T T C/C C/C
rs6122041 C/C T/C T/C C T/C T/T
rs2427554 A/A G/A G/A A G/A G/G
rs6011226 A/A T/A T/A A T/A T/T
DNAJC6 Leu116del Leu116del Leu116del Leu116del Leu116del Leu116del
Two informative homozygous discordant genotypes close to the Leu116del change indicate that the Parry family does not share a haplotype with either of the two
families reported in Noskova et al supporting a mutational hotspot rather than a founder effect. Grey: Noskova et al [4] haplotypes; Red: Discordant homozygous
genotypes; all markers appear in their genomic order from centromere to telomere.
doi:10.1371/journal.pone.0029729.t003
Table 4. Haplotype reconstruction with genetic markers in DNAJC5.
Leu115Arg
BD319 UCL328 N1 UCL563
rs2065993 A/A genotypes; all markers appear in their genomic
order from centromere to telomere.A/A
G/G G/G
rs2247381 G/G G/G A/A A/A
rs2427546 C/C C/C T/T T/T
rs2427547 G/G G/G A/G A/A
rs2427550 A/A A/A C/C C/C
rs2427551 G/G G/G A/A A/A
rs2427552 G/A G/A G/G G/G
rs6011225 C/C n/a A/C C/C
rs2427549 C/C n/a C/C C/C
rs2427548 T/T n/a C/C C/C
rs2427553 A/A C/C C/C C/C
rs6062586 T/T C/C C/C C/C
rs6122041 C/C C/C T/T T/T
rs2427554 A/A A/A G/G G/G
rs6011226 A/A A/A T/T T/T
DNAJC5 Leu115Arg Leu115Arg Leu115Arg Leu115Arg
Three homozygous discordant genotypes close to the Leu115Arg change indicate that family BD319 does not share a haplotype with the three families reported in
Noskova et al supporting a mutational hotspot rather than a founder effect. Grey: Noskova et al haplotypes; Red: Discordant homozygous genotypes; all markers appear
in their genomic order from centromere to telomere.
doi:10.1371/journal.pone.0029729.t004
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We have performed exome sequencing on a large pedigree with
ADKD and identified two highly significant changes in two
neighboring genes on chromosome 20, which segregated with the
phenotype. By screening additional ADKD patients we found an
additional significant change in one family in the gene DNAJC5,
but none in the gene PRPF6. We thus conclude, in agreement with
the recent study by Noskova et al [4] that DNAJC5 is a new gene
causing ADKD in a subset of families with the disease. DNAJC5
(MIM611203) codes for the protein Cystein String Protein alpna
(CSPa). CSPa is highly conserved and is expressed in the brain. It
associates with proteins SGTA and HSPA8 in a complex located
on the synaptic vesicle surface that is believed to have a role in
maintenance of the synapse function [8]. CSPa-deficient mice
appear normal at birth, but at 2–4 weeks develop a fatal
progressive disorder that includes muscle weakness and sensori-
motor deficiency [9].
The additional identification of a significant change in PRPF6 in
the Parry family is of interest. PRPF6 is a pre-mRNA splicing
factor important in the formation of the spliceosome. The encoded
protein has been shown to bind to the androgen receptor thus
potentially linking transcriptional activation and splicing. Muta-
tions in PRPF6 and other pre-mRNA splicing factors have been
reported to cause rare forms of autosomal-dominant retinitis
pigmentosa [7]. Retinitis pigmentosa is not a consistent feature of
ADKD, but several family members of the Parry family have been
reported with apparently functional vision problems (see methods
and reference 5). Given that both changes in DNAJC5 and PRPF6
were not identified in a large number of controls and their
complete co-segregation within the extended pedigree, it can be
assumed that they fall on the same rare haplotype. Since limited
information regarding the visual status of members of the Parry
family exist, it was impossible to follow visual phenotype
segregation in the family. Therefore further clinical studies of
the family are needed in order to reach a definite conclusion about
the role of the PRPF6 sequence change as a phenotype modifier.
We report a detailed clinical description of the Pary family
proband in order to provide a detailed DNAJC5 deficiency-
associated phenotype. Several conclusions can be made from the
reported phenotypes of the proband and her relatives.. Firstly, no
reliable confirmation of Kufs disease in individuals with DNAJC5
mutations could be made by studying peripheral cells for lysosomal
inclusions in the earlier stages of the disorder. It seems that the EM
studies of peripheral cells in DNAJC5 mutation-negative individ-
uals tend to be more informative, compared to those in mutation-
positive individuals, but this remains to be confirmed in further
studied (see Table 2). This emphasizes the usefulness of conducting
a molecular study for DNAJC5 mutations when ADKD is
suspected. Such testing will be likely available soon. Secondly,
psychiatric manifestations may be the first presentation in DNAJC5
positive individuals. The proband of the Parry family presented
with such manifestations long before other symptoms were noted.
While the current study was underway, mutations in DNAJC5
were reported in 5 ADKD individuals [4]. 20 individuals from
different families were included in this study. However only seven
had a clear autosomal dominant inheritance. Also, results of
confirmatory neuropathological studies of brain tissue were not
reported for the individuals negative for DNAJC5 mutations. It is
thus difficult to determine the exact proportion of ADKD
individuals with DNAJC5 mutations from the report of Noskova
et al. since no reported laboratory confirmation of ADKD in most
mutation-negative individuals/families was available.
Our study included only individuals/families with known
autosomal dominant inheritance or sporadic individuals thus
minimizing the likelihood of families with recessive inheritance.
Most importantly, all affected individuals in the present study had
confirmation of the diagnosis of Kufs disease by neuropathological
studies of the brain. In our set two out of nine individuals/families
(22%) had DNAJC5 mutations. If we only consider strictly known
autosomal dominant families then 1 out of 5 families (20%) had a
DNAJC5 mutation. It is therefore clear that other genes are
involved in the majority of ADKD cases (up to 80% in our
sample).
In the group of NCL, ADKD is classified as NCL 4B (MIM
162350). We propose that the type of ADKD that is associated
with mutations in DNAJC5 is classified as NCL 4B1.
In summary, we have identified variants in DNAJC5 as cause for
ADKD in approximately 20% of autosomal-dominant families,
confirming a recent report by Noskova et al [4]. We conclude that
additional genetic studies will be necessary to identify the
remaining genes for ADKD and fully characterize the molecular
genetic spectrum of this disease.
Limitations
It is not possible to rule out with certainty recessive inheritance
in our sporadic cases, but if only individuals with clearly
documented autosomal-dominant inheritance in our study are
considered, the prevalence of DNAJC5 mutation-positive individ-
uals does not change significantly compared to the value using all
individuals studied (about 20%). It thus appears that most genetic
mutations associated with ADKD remain to be identified.
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